As Roche comes under competitive pressure on its breast cancer business, the Swiss company hopes a new drug will add a ...

A new campaign from Opella, Sanofi’s consumer health unit, is a royal flush. | A new campaign from Opella, Sanofi’s consumer ...

Lilly has earmarked $200 million for the upgrade, a company spokesperson confirmed to Fierce Pharma. The new project will ...

Thermo Fisher Scientific is responsible for helping to produce some of the hottest drugs on the market, including Novo ...

With reports swirling about potential interest in Sanofi’s consumer health business, the French pharma has confirmed that a ...

The survey suggests ads can improve health management. Almost half of patients said ads help them make informed decisions ...

Six months after scoring FDA approval for hemophilia B gene therapy Beqvez, Pf | For the second time in six months, the FDA ...

AstraZeneca has bagged a cardiovascular disease candidate from China's CSPC Pharma in a deal potentially worth $2 billion.

The agreement frees the British pharma giant from litigating 93% of the state court cases it faced in the U.S.

Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...

In prostate cancer, Pfizer’s Talzenna already holds the broadest FDA approval within the PARP inhibitor class. | In prostate ...

Through allocations, Baxter is limiting how much customers can order based on their past purchases, medical necessity and ...